The role of alpha(v)beta(3) in prostate cancer progression - PubMed (original) (raw)

Review

The role of alpha(v)beta(3) in prostate cancer progression

Carlton R Cooper et al. Neoplasia. 2002 May-Jun.

Abstract

Integrin alpha(v)beta(3) is involved in varied cell biological activities, including angiogenesis, cell adhesion, and migration on several extracellular matrix components. Although alpha(v)beta(3) is not typically expressed in epithelial cells, it is expressed in macrophages, activated leukocytes, cytokine-stimulated endothelial cells, osteoclasts, and certain invasive tumors. Interestingly, the adhesion and migration of breast cancer cells on bone matrix are mediated, in part, by alpha(v)beta(3). Similar to breast cancer cells, prostate cancer cells preferentially metastasize to the bone. The biological events that mediate this metastatic pattern of prostate cancer are not well defined. This review discusses the role alpha(v)beta(3) plays in prostate cancer progression, with specific emphasis on bone metastasis and on alpha(v)beta(3) signaling in prostate cancer cells. The data suggest that alpha(v)beta(3), in part, facilitates prostate cancer metastasis to bone by mediating prostate cancer cell adhesion to and migration on osteopontin and vitronectin, which are common proteins in the bone microenvironment. These biological events require the activation of focal adhesion kinase and the subsequent activation of PI-3 kinase/Akt signaling pathway.

PubMed Disclaimer

Figures

Figure 1

Figure 1

αvβ3 signaling pathway in prostate cancer cells. Ligation of αvβ3 with multiple ligands (i.e., osteopontin, BSP, or vitronectin) activates FAK, which interacts and activates PI-3 kinase [23]. The products of PI-3 kinase activity recruit PKB/Akt to the cell membrane where it is activated by phosphorylation and it phosphorylates several substrates to elicit a variety of biological responses, including cell survival, adhesion, and migration. Although NF-κB is potentially involved in the αvβ3 signal transduction pathway [8], its role in this signaling pathway is not known for prostate cancer cells.

Similar articles

Cited by

References

    1. Schmelz M, Cress AE, Scott KM, Burger F, Cui H, Sallam K, McDaniel KM, Dalkin BL, Nagle RB. Different phenotypes in human prostate cancer: α6 or α 3 integrin in cell-extracellular adhesion sites. Neoplasia. 2002;4:243–254. - PMC - PubMed
    1. Varner JA, Cheresh DA. Tumor Angiogenesis and the Role of Vascular Cell Integrin αvβ3. In: DeVita VT, Hellman S, Rosenberg SA, editors. Important advances In Oncology. Philadelphia, PA: Lippincott-Raven Publishers; 1996. pp. 69–87. - PubMed
    1. Teitelbaum SL, Ross FP. Mechanisms of tumor-induced osteolysis. Lab Invest. 1994;71:453–455. - PubMed
    1. Ross FP, et al. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alphaVbeta3 potentiate bone resorption. J Biol Chem. 1993;268:9901–9907. - PubMed
    1. Cheng S-L, et al. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem. 2000;77:265–276. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources